stockNASDAQ: HALO • 28 Days Updates
Halozyme Therapeutics Inc. (HALO)
Showing Closing Date Range from Sep 4 to Oct 2, 2026.
Halozyme Therapeutics Inc. (HALO) is a publicly traded company operating within the Health Care sector.
Investor Relations:ir.halozyme.com
Price & Performance Trajectory
Halozyme Therapeutics Inc.NASDAQ: HALO
Latest Close
$109.86
28 Days Updates Trajectory
Showing Closing Date Range from Sep 4 to Oct 2, 2026.Loading trajectory chart...
Click metric scorecards below to toggle price, return %, range & volume curvesHALO session performance
✓ Latest Close USD
$109.86
Latest session close
$-0.33vs period start
Period Return % % GAIN
-0.3%
Net period trajectory
Cumulative ReturnNormalized
High / Low Range SPREAD
$116.85 / $105.5
Period range envelope
$11.35channel spread
Total Volume SHARES
47.77M
Period turnover
Avg: 2.51M/dLiquidity
Historical Session Ledger
Daily open, high, low, and close prices with volume and period returns.
Historical Quotes & Breakdown(19 dates)
| Date | Close (USD) | Return % | High | Low | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | $109.86 | +2.73% | $109.99 | $106.65 | 2.59M |
| Oct 01, 2026 | $106.94 | -3.13% | $110.50 | $106.84 | 2.33M |
| Sep 30, 2026 | $110.40 | -1.04% | $112.45 | $110.35 | 3.52M |
| Sep 29, 2026 | $111.56 | -1.18% | $114.52 | $111.03 | 2.87M |
| Sep 28, 2026 | $112.89 | -0.89% | $113.94 | $112.10 | 2.24M |
| Sep 25, 2026 | $113.90 | -1.15% | $115.63 | $113.43 | 1.96M |
| Sep 23, 2026 | $112.44 | -2.34% | $116.85 | $112.18 | 2.70M |
| Sep 22, 2026 | $115.13 | +3.30% | $115.18 | $110.95 | 4.13M |
| Sep 21, 2026 | $111.45 | -0.89% | $113.47 | $111.05 | 2.88M |
| Sep 18, 2026 | $112.45 | +2.53% | $112.66 | $109.38 | 10.18M |
| Sep 17, 2026 | $109.68 | +1.14% | $110.88 | $106.82 | 1.98M |
| Sep 16, 2026 | $108.44 | +2.06% | $109.63 | $105.50 | 1.71M |
| Sep 15, 2026 | $106.25 | -1.57% | $108.14 | $106.14 | 1.06M |
| Sep 14, 2026 | $107.94 | +0.69% | $108.61 | $106.65 | 912.5K |
| Sep 11, 2026 | $107.20 | +0.19% | $108.23 | $106.34 | 861.5K |
Page 1 of 2